News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Brookfield trades near $45.87 with $2.3B free cash flow and ~4.1% yield, and a structured long with $42.20 stop/$58 target is recommended.
  • Embraer shows order momentum and rising production cadence, prompting a mid-term recovery trade with a disciplined stop.
  • Fifth Circuit ruled ICE must offer bond hearings after 90 days under the mass detention policy, potentially affecting thousands in its jurisdiction.
  • Brookfield's buy-the-dip call could lift asset-management and renewable infrastructure stocks in the near term.
  • The ICE decision may boost immigration court caseloads and bond hearing workloads across Fifth Circuit states.

Latest Articles

AWS to Lift GPU Reservation Rates About 20% Starting July 1, 2026

AWS to Lift GPU Reservation Rates About 20% Starting July 1, 2026

Amazon Web Services will increase hourly prices for EC2 Capacity Block reservations for several Nvidia-powered GPU instance families by roughly 20% effective July 1, 2026. The change affects top-tier P6 and P5 families and follows strong cloud revenue growth and heavy capital commitments to AI infrastructure. Enterprises using reserved capacity fac…

Quantum Corp. Shares Slide After Northland Lowers Rating, Keeps $13 Target

Quantum Corp. Shares Slide After Northland Lowers Rating, Keeps $13 Target

Quantum Corp. (NASDAQ:QMCO) experienced an intraday pullback after Northland cut its rating to Market Perform from Outperform while leaving its $13.00 price target unchanged. The downgrade follows a notable run-up in the stock from roughly $7 a share at the time of Northland's November 2025 upgrade to about $13 today. Northland analyst Nehal Choksh…

UBS Sees Temporary Weakness in Oil as Gulf Supply Restoration Lags

UBS Sees Temporary Weakness in Oil as Gulf Supply Restoration Lags

UBS has cut its crude oil price forecasts following a roughly $15 per barrel drop in Brent in the 10 days after a U.S.-Iran memorandum of understanding, with Brent sliding below $73 a barrel. The bank says the immediate weakness reflects a surge of supply from previously stranded tankers and strategic reserve draws, but expects a rebound in coming …

Crocs Shares Lifted by Piper Sandler Upgrade and Strong Q1 Results

Crocs Shares Lifted by Piper Sandler Upgrade and Strong Q1 Results

Crocs jumped in pre-market trading after Piper Sandler upgraded the stock from Neutral to Overweight and lifted its price target from $95 to $150. The upgrade followed a solid first-quarter 2026 report that beat earnings and revenue estimates and included a raised full-year outlook. Company-specific optimism, including confidence in North American …

Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference

Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference

Capricor Therapeutics announced robust five-year data from its HOPE-2 open-label extension study and positive results from the HOPE-3 Phase 3 trial of Deramiocel, its lead cell therapy for Duchenne Muscular Dystrophy (DMD). The data demonstrate durable benefits in both skeletal and cardiac muscle function, with a favorable safety profile over time.…

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress

Hemab Therapeutics announced new clinical and preclinical data presentations at the ISTH 2026 Congress, highlighting advances in their pipeline for blood coagulation disorders. Key updates include positive first-in-human Phase 1/2 data for HMB-002 in Von Willebrand Disease showing elevated VWF and FVIII levels, sustained bleeding reduction in Phase…

Verizon to report earnings July 24, 2026

Verizon to report earnings July 24, 2026

Verizon Communications Inc. plans to report its financial results for the second quarter of 2026 on July 24, 2026. The company will host a webcast presenting the results starting at 8:30 a.m. ET, with related materials available on its Investor Relations website earlier in the day. Verizon remains a major player in the telecommunications sector, se…

Gildan Recognized as One of Canada’s Best 50 Corporate Citizens by Corporate Knights and Among TIME’s World’s Most Sustainable Companies

Gildan Recognized as One of Canada’s Best 50 Corporate Citizens by Corporate Knights and Among TIME’s World’s Most Sustainable Companies

Gildan Activewear Inc. has been recognized for the fifth consecutive year as one of Canada's Best 50 Corporate Citizens by Corporate Knights and has also featured again in TIME's World's Most Sustainable Companies ranking. This recognition highlights the company's ongoing commitment to sustainability within its corporate strategy, reflecting strong…

Omeros Shares Plummet After EMA Panel Issues Negative Opinion on Narsoplimab

Omeros Shares Plummet After EMA Panel Issues Negative Opinion on Narsoplimab

Omeros Corporation's stock dropped sharply in premarket trading after the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on the company's application to market narsoplimab for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). The company said it will reque…